AU8536398A - Incorporation of pharmacologically active amino acid analogues into proteins - Google Patents

Incorporation of pharmacologically active amino acid analogues into proteins

Info

Publication number
AU8536398A
AU8536398A AU85363/98A AU8536398A AU8536398A AU 8536398 A AU8536398 A AU 8536398A AU 85363/98 A AU85363/98 A AU 85363/98A AU 8536398 A AU8536398 A AU 8536398A AU 8536398 A AU8536398 A AU 8536398A
Authority
AU
Australia
Prior art keywords
incorporation
proteins
amino acid
pharmacologically active
acid analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85363/98A
Inventor
Nediljko Budisa
Robert Huber
Carolin Minks
Luis Moroder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of AU8536398A publication Critical patent/AU8536398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU85363/98A 1997-06-11 1998-06-05 Incorporation of pharmacologically active amino acid analogues into proteins Abandoned AU8536398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19724670A DE19724670A1 (en) 1997-06-11 1997-06-11 Incorporation of pharmacologically active amino acid analogs into proteins
DE19724670 1997-06-11
PCT/EP1998/003398 WO1998056824A2 (en) 1997-06-11 1998-06-05 Incorporation of pharmacologically active amino acid analogues into proteins

Publications (1)

Publication Number Publication Date
AU8536398A true AU8536398A (en) 1998-12-30

Family

ID=7832171

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85363/98A Abandoned AU8536398A (en) 1997-06-11 1998-06-05 Incorporation of pharmacologically active amino acid analogues into proteins

Country Status (4)

Country Link
EP (1) EP0998487A2 (en)
AU (1) AU8536398A (en)
DE (1) DE19724670A1 (en)
WO (1) WO1998056824A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10255132A1 (en) * 2002-11-26 2004-07-15 Max Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Composition containing peptide that includes amino acid analog, useful for treating e.g. cancer, where the peptide binds to and enters only specific target cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061693A (en) * 1989-07-28 1991-10-29 Merck & Co., Inc. Fibrinogen receptor antagonists
NL9200481A (en) * 1992-03-13 1993-10-01 Univ Groningen PHARMACEUTICAL PREPARATION WITH PLACE-ORIENTED DELIVERY.
JPH0940577A (en) * 1995-05-24 1997-02-10 Mitsui Toatsu Chem Inc Medicinal composition containing tripeptide or dipeptide

Also Published As

Publication number Publication date
DE19724670A1 (en) 1998-12-24
WO1998056824A2 (en) 1998-12-17
WO1998056824A3 (en) 1999-04-08
EP0998487A2 (en) 2000-05-10

Similar Documents

Publication Publication Date Title
AU5420499A (en) Novel aryl sulphonamide amino acid esters and analogues
AU2484399A (en) Controlled release delivery of peptide or protein
AU6883298A (en) An engineered seed protein having a higher percentage of essential amino acids
ZA9811327B (en) Compositions and methods for altering amino acid content of proteins
ZA989740B (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
PL335974A1 (en) Method of orally administering proteins
AU3826899A (en) Peptide analogues of pacap
AU3321595A (en) Recombinant production of biologically active peptides and proteins
AU8166098A (en) Removal of biologically active agents
AU2548097A (en) Formulations of ob protein
AU2091799A (en) Uses of alpha-conotoxin peptides
AU7758598A (en) Stable pharmaceutical administration forms of peptides, proteins and nucleic acids
AU8912698A (en) Inhibition of hiv-1 replication using d-amino acid peptides
PL327786A1 (en) Pharmaceutical preparations of cilansterone stabilised against racemisation
NO963000D0 (en) Improved digestibility of pharmaceutically active amino acids
AU1684099A (en) Amino acid derivatives
AU3407597A (en) Useful formulations of acid addition salt drugs
AU4120096A (en) Production of recombinant peptides as natural hydrophobic peptide analogues
AU1616901A (en) Beryllofluoride analogues of acyl phosphate polypeptides
AU8536398A (en) Incorporation of pharmacologically active amino acid analogues into proteins
AU3494093A (en) S-lipophilic aliphatic carbonyl {n-mercaptoacyl-(amino acid or peptide)} compounds as antihypertensive agents
AU6843498A (en) Process for the preparation of n-(3-hydroxy-succinyl)-amino acid derivatives
AU4546196A (en) Amino acid compositions
AU5337198A (en) Production of biologically active polypeptides
AU8573598A (en) Novel azatyrosine analogues and process of preparation thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase